| For: | Park J, Jeong JY, Kim SS, Yoon JH, Eun HS, Choi J, Yoon KT, Jung YK, Park SY, Gwak GY, Kim DY, Kim JH, Lee JW, Kim TY, Jang JW, Yu SJ. Chrono-optimal treatments for human immunodeficiency virus/hepatitis C virus co-infection yield comparable survival outcomes with hepatitis C virus mono-infection. World J Gastroenterol 2026; 32(3): 114176 [PMID: 41640617 DOI: 10.3748/wjg.v32.i3.114176] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v32/i3/114176.htm |
| Number | Citing Articles |
| 1 |
Tian-Ju Li. Integrating hepatitis C care into human immunodeficiency virus clinics in the direct-acting antiviral era: From biological disadvantage to structural opportunity. World Journal of Gastroenterology 2026; 32(36): 118426 doi: 10.3748/wjg.118426
Abstract(61) |
Core Tip(58) |
Full Article(HTML)(262)
|
Full Article (PDF)-6406K(32)
|
Full Article with Cover (PDF)-6809K(19)
|
Full Article (XML)-106K(20)
|
Audio-783K(0)
|
Peer-Review Report-272K(23)
|
Answering Reviewers-144K(20)
|
Supplementary Material-188K(18)
|
Times Cited (0)
|
Total Visits (414)
|
Open
|
| 2 |
Guangchao Zhou, Juanyan Liao, Haolin Tang, Xingyu Hou, Qing Li, Xia Li. HIV-driven tumor ecosystem: from chronic immune dysfunction to cancer evolution. Frontiers in Microbiology 2026; 17 doi: 10.3389/fmicb.2026.1901762
|